





BMP2 repression and optimized culture conditions promote human bone marrow-derived mesenchymal stem cell isolation
Abstract
Aims
Human mesenchymal stem cells (hMSC) are multipotent progenitor cells. We propose the optimization of hMSC isolation and recovery using the application of a controlled hypoxic environment. 
Materials and Methods
We evaluated oxygen, glucose and serum in the recovery of hMSC from bone marrow (BMhMSC). Colony forming units-fibroblastic (CFU-F), cell numbers, tri-lineage differentiation, immunofluorescence, and microarray were used to confirm and characterize BMhMSC.
Results
In an optimized (2% O2, 4.5g/L glucose, and 5% serum) environment both CFU-F (p=0.01) and cell numbers (p=0.0001) were enhanced over standard conditions . Transcriptional analysis identified differential expression of bone morphogenetic protein 2 (BMP2) and, putatively, chemokine (C-X-C motif) receptor 2 (CXCR2) signaling pathways. 
Conclusions
We have detailed a potential milestone in the process of refinement of the BMhMSC isolation process.
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Human mesenchymal stem cells (hMSC) are multipotent progenitor cells that can be isolated from multiple tissues including, amongst others, bone marrow and adipose tissues. MSC were first identified and described over half a century ago and their differentiation capacity and immunophenotype have since undergone rigorous examination[1,2]. hMSC have a generally accepted inherent mesodermal differentiation capacity and the potential for neuronal lineage generation. Immunophenotyping has produced a broad panel of positive and negative markers which characterize a cell as a mesenchymal stem cell, although practicalities (e.g. cell numbers, antibody availability) limit the number of markers which are routinely used for evaluation [3]. 

The wealth of experience surrounding hMSC from bone marrow (BMhMSC) culture and characterization has unsurprisingly led to the emergence of a broad range of clinical trial applications [4], including myocardial infarction, osteoarthritis, graft versus host disease, stroke, liver cirrhosis, and both Type I and Type II diabetes (www.clinicaltrials.gov). Trial outcomes have been promising, although the mechanisms of action are unclear, and are accompanied by poor rates of post-transplant cell survival [5].

The terms physiological normoxia, reduced oxygen, and hypoxia have been applied in studies to describe the culture atmosphere in investigations of the culture of cells in oxygen tensions lower than atmospheric levels, i.e. <21% O2 [6-8]. The broad aim of these studies is to either recreate the niche-like conditions found in normal tissue compartments or  those encountered in diseased tissue states such as tumor growth. The application of reduced oxygen tensions to stem cell research has produced descriptions of stem cell types including embryonic, hematopoietic, neuronal, and hMSC [6,7,9-14]. Enhanced clonogenicity, reduced spontaneous differentiation, minimized epigenetic shift, transcriptional alterations, improved chromosomal stability, and increased numbers of differentiation target cells are consistently associated with culture of stem cells in reduced oxygen tensions (2-5% O2) in comparison to an ambient air (20% O2) setting [5,10,12,14-19].

Physiological normoxia within bone marrow is within the range of 2-8% O2 where niches which support stem cell populations are hypothesized to occupy the lower end of the scale [20]. Routine isolation, culture, characterization, and differentiation of hMSC have traditionally been performed under 20% O2 conditions consistent with standard cell culture practice. More recently, several studies have described the application of physiological normoxia in these procedures. However, taken in cross-section, findings are inconsistent, frequently contradictory, and no consensus outcome is reported [5,21-33].

Similarly, serum concentrations ranging from 5% to 20% serum have all been applied to hMSC isolation [5,10,21-23,25-29,34-37]. In addition to these, a number of studies have described the evaluation of serum-free approaches to the isolation of hMSC from bone marrow where control serum values ranging from 10% to 15% were employed [38-41]. In these studies it is not possible to ascertain the role, if any, of a reduced serum concentration vs. serum-free counterparts in hMSC isolation. Identification of optimal serum concentrations for the isolation of BMhMSC would simplify and enable direct cross-comparison to take place in the absence of distinct variables. 

An additional variable which has received some interest in evaluation of effects on hMSC biology and isolation is glucose. Cell culture media utilized in the isolation of hMSC from bone marrow is typically either 1g/L or 4.5g/L glucose. Reports have indicated that hMSC display metabolic flexibility such that variations in glucose levels can alter pathway preference from oxidative phosphorylation to aerobic glycolysis, reversibly, depending on the prevailing environmental conditions [42-44]. Moreover it is also apparent that MSC require glucose to survive in ischemic environments but not in chronically low oxygen environments, reinforcing the previously described importance of metabolic flexibility in these cells [45]. 






BMhMSC isolation and culture methodology
BMhMSC were isolated from commercially sourced donor bone marrow aspirate retrieved from the iliac crest of 11 donors aged between 18 and 45 (Lonza, USA). Bone marrow aspirates were transported under controlled temperature conditions (20oC) and supplemented with heparin to prevent coagulation. Aspirates were accompanied by mononuclear cell counts and were gently agitated to resuspend all cells prior to seeding. Seeding was performed within 48 hours of aspiration where previous findings detail 80-90% mononucleated cell (MNC) viability [46]. BMhMSC isolation and expansion was performed using a modification of a previously described protocol which does not incorporate a separate MNC isolation step, for instance, density centrifugation [10,47]. Briefly, whole bone marrow was seeded at a density of 105 MNC/cm2 on a minimum of six 10ng/mL fibronectin-coated flasks per donor per condition; 3 flasks were Giemsa stained for Colony forming unit – Fibroblastic (CFU-F) quantification and 3 flasks were used to determine final cell counts and for RNA isolation. Additional flasks were seeded for use in differentiation assays or immunofluorescence. MNC were seeded into either high-glucose Dulbecco’s-Modified Eagles Media (DMEM) (4.5g/L, GH) or low-glucose DMEM (1.0g/L, GL). Media was supplemented with either 10% (SH,) or 5% (SL) batch-tested FBS (Lonza, USA), 100 U/mL penicillin, 100 U/mL streptomycin, 1% NEAA, and 1% L-Glutamine (all Lonza, UK). Penicillin was included initially to counteract the inherent infection risk associated with the culture of primary materials. Media was passively deoxygenated in hypoxic conditions post cell seeding to bypass inconsistencies associated with pre-incubation of media in hypoxic conditions. After 7 days half of the culture medium was replaced with fresh antibiotic-free media; after 14 days media was replaced completely again without the inclusion of antibiotic. At Day 21, the flasks were washed and fixed with 10% Neutral Buffered Formalin for CFU-F Giemsa stain-based quantification, or harvested for cell counting and RNA isolation. Day 21 cells were classified as passage 0 (P0). Giemsa staining was performed as described elsewhere [46]. CFU-F numbers were determined microscopically where Giemsa stained clusters of greater than 16 cells were positively scored [48]. For immunofluorescence characterization fresh bone marrow aspirate was seeded into 24-well plates at the seeding density indicated above. BMhMSCs were recovered over 21 days and then washed and fixed, as P0, and as described below. For differentiation potential determination BMhMSC were again isolated as described above and then stimulated as described below. Cells were not passaged for initial characterization experiments and are therefore classified as P0. BMhMSC recovery was performed in either humidified incubators or hermetic workstations set at 37°C, 7% CO2, and varying O2 concentrations: either 20% O2 (standard incubator), 2% O2 (single-use incubator, multi-user incubator, workstation (RS Biotech, UK and Ruskinn, UK), flushbox (15)), and 0.2% O2 (flushbox). Reductions in O2 were achieved by either controlled N2 purging of standard tri-gas incubators (RS Biotech, Irvine, UK) using a N2 generator (Peak Scientific, UK) or by purging flushboxes with pre-mixed gas. For exogenous BMP2 supplementation 50 ng/mL BMP-2 (Gibco/Life Technologies) was added over the duration of CFU-F recovery, as described above. Cell counts were performed with a haemocytometer where trypan blue exclusion was included as a measure of viability.

Immunofluorescence
Fresh bone marrow was seeded into 24-well plates, as described above, and P0 BMhMSCs recovered over a 21 day period. Cells were fixed with 4% paraformaldehyde, blocked with 3% BSA (Bovine serum albumin), and incubated overnight at 4oC with anti-CD44, anti-CD90, anti-CD146, anti-CD14, anti-CD19 and anti-STRO-1 primary antibodies (Human MSC Characterization Kit. Cat. No. SCR067, Millipore). Secondary antibody incubation was at room temperature for 2 hours before washing and mounting in Dapi-Vectashield Secondary antibodies anti-mouse IgG-NL557 (CD44, CD90, CD146, CD144, CD19) and anti-mouse IgM-NL493 (STRO-1). Representative images are presented for all of the above CD markers. For quantitative analysis, STRO-1 positive BMhMSCs were counted per field at 20X magnification. Three fields were counted from each well of a triplicate experiment on P0 and passage 1 (P1) BMhMSCs. In this instance BMhMSC were passaged at Day 21 by first washing with PBS followed by exposure to Trypsin/EDTA until cells detached. After enzymatic quenching with excess medium BMhMSC were centrifuged at 1000 rpm for 2 minutes and then seeded at 1:2 passage ratios. Reseeded cells were classed as P1 and were fixed, described above, after a further 14 days in culture.

Differentiation
Differentiation assays were performed as described elsewhere [16]. In brief, BMhMSC were isolated as described above and after 21 days media was replaced with either osteogenic, adipogenic or chondrogenic medium and cells maintained for a further  21 days before being fixed and characterized by histological staining. To detect osteogenesis, fixed cells were immersed in 1% Alizarin Red solution for 5 min followed by washes in distilled water until effluent was clear. To detect chondrogenesis, fixed cells were stained overnight in 0.1% Alcian Blue solution at pH 1.5 followed by rinses in distilled water to remove excess stain. Adipogenesis was detected by first rinsing fixed cells in 60% isopropyl alcohol before staining with a 0.18% Oil Red O/60% isopropyl alcohol solution for 5 minutes. Samples were washed in tap water until clear. Differentiation was detected microscopically and images captured where positive staining had occurred. For chondrogenesis, a micromass approach was adopted according to the manufacturer’s instructions (StemPro Chondrogenesis Differentiation Kit (Invitrogen)). Differentiated cell image capture was performed with either a 10X (osteogenesis) or 40X objective (chondrogenesis and adipogenesis) on an Eclipse TS100 (Nikon) with an EOS 400D (Canon). Immunofluorescence images were captured with a 20X objective on an Eclipse Ti-S (Nikon) inverted microscope system with a DS-Fi1 (Nikon) high definition color camera head using appropriate filter sets.

Microarray Analysis
RNA was extracted from day 21, P0, harvested BMhMSC cell pellets archived from a single donor recovered in GHSLO2%WS (X4 individual cell pellets), GHSLO2% (X4 individual cell pellets), and GHSHO21% (X4 individual cell pellets) with lysis, homogenization and extraction performed according to manufacturer’s guidelines (QIAShredder; RNeasy (Qiagen). Whilst clear advantages exist to performing microarray-based analysis across multiple donors, the selection of a single donor approach for candidate identification followed by multiple donors for verification purposes allowed similar stringency levels to be applied. RNA was first rRNA reduced followed by first and second strand cDNA synthesis and transcription. cRNA was subsequently cleaned, transcribed into cDNA, cleaned again, fragmented, labeled, and hybridized overnight onto Exon 1.0ST arrays before washing, staining, and scanning. All procedures were performed according to manufacturer’s guidelines (Affymetrix). Hybridization, washing and scanning were performed using a GeneChip Hybridisation Oven 640, GeneChip Fluidics Station 450, and 7G GeneChip Scanner 3000 (Affymetrix).

Quantitative RT-PCR was performed against a discrete selection of genes which displayed differential expression in response to varying O2 conditions to provide secondary, independent, verification of array data. qRT-PCR was performed using triplicate independent RNA isolates from hMSC isolated from three independent donors. Primer sequences and candidate gene were; CXCL1 (5’-TCACCCCAAGAACATCC-3’ (Forward), 5’- GCTGAACAGTGACAAATCC -3’ (Reverse)); PTGIS (5’-TGTCTTCCACACCTTTCG -3’ (Forward), 5’- GGAGATGGGTGTGTCAGA-3’ (Reverse)); and ACAN (5’- TCTGAGGGTCATCACTGC-3’ (Forward), 5’- CTTCTCCTTGGACACACG-3’ (Reverse)). Expression was normalized against GAPDH (5’- GACTTCAACAGCGACACC-3’ (Forward), 5’- GCAAGAGCACAAGAGGAA-3’ (Reverse)). Genes were randomly selected for inclusion in this analysis from the 80 gene BMhMSC core transcriptional footprint. 

Bioinformatics analysis
CEL files were subsequently exported from the Affymetrix Workstation and imported into DChip (2008 build) for quality control and normalized using median probe intensity as baseline array. Exon level expression data were first generated and then exported as U133 Plus 2.0 data using the supplied mapping file. Data sample groupings were then established, values sorted according to expression, and selected based on fold changes of >2 and statistical significance, p<0.05. Ontological and KEGG pathway analysis was performed on the DAVID Bioinformatics Resource using appropriately selected identifiers and background formats [49,50].

Statistical Analysis
Statistical analysis was performed using Minitab 15.0, Graphpad Prism 4 and Origin 8.1 with further analysis performed in Microsoft Excel Spreadsheets application. A Paired Students T-test was used in comparative evaluation of CFU-F and BMhMSC cell yields with p<0.05 considered significant. Microarray data was analyzed using dChip software with the DAVID bioinformatics resource and a Paired Student's T-test used to identify statistically significant variations in gene expression. 
Results

Reports describing the efficacy of isolation of hMSC from bone marrow aspirates vary in the application of reduced oxygen, serum concentration and glucose level. To establish a background methodology for the recovery of BMhMSC we tested a matrix of glucose (G); High (GH), 4.5g/L and Low (GL), 1g/L, serum (S); High (SH) 10% and Low (SL), 5%, and oxygen (O); 20% O2 (O20%), 2% O2 (O2%), and 0.2% O2 (O0.2%). Determination of the optimal matrix point, as defined by the greatest number of CFU-F, was made by seeding bone marrow aspirate into each grouping in triplicate from each of three independent donors. CO2/N2 incubators remained unopened except when media changes were required during the CFU-F recovery process unless otherwise indicated. 

Quantification of CFU-F showed that cultivation and expansion under standard conditions (GHSHO20%) yielded a mean of 28.6 CFU-F/75 cm2, while optimal CFU-F recovery was observed in GLSLO2% and GHSLO2% (48.3 CFU-F/75 cm2 and 49.3 CFU-F/75 cm2 respectively) (Figure 1A). Mean values were calculated from triplicate samples for each donor; mean values from each donor were then pooled to generate an overall mean as presented in Figure 1. Widespread variance was observed between the three initial donors (p<0.0001) resulting in noticeable differences in CFU-F recovery which did not achieve significance levels. The proliferative potential of BMhMSC recovered at differing matrix points was broadly reflective of initial CFU-F yield with minor exceptions (for example, GLSLO20%, GLSLO2%, and GLSLO0.2% underwent rapid replicative exhaustion (data not shown)). We next tested bone marrow aspirate from a further six independent donors seeded into GHSHO20%, GHSLO20%, and GHSLO2% representing standard, intermediary (where serum was the solitary component altered), and optimal recovery conditions, respectively, in triplicate. Increasing sample numbers again produced an increase in variability, with GHSHO20% on this occasion yielding a greater number of CFU-F than GHSLO20% (55.25 CFU-F/75 cm2 vs. 33 CFU-F/75 cm2) though GHSLO2% remained optimal (80.9 CFU-F/75 cm2, p=0.001 vs. GHSHO20% /GHSLO20%) (Figure 1B). However, irrespective of CFU-F frequency, BMhMSC recovery per flask, expressed as either per T75 flask or per 106 MNC seeded, followed a clear hierarchy of GHSLO2% > GHSLO20% > GHSHO20% (Figure 1C and 1D, p<0.05 vs. GHSHO20% /GHSLO20%).

We next sought to establish whether variations in the degree of hermetic (airtight) control had any direct consequence on BMhMSC yield. We seeded MNC from a single donor into flasks contained in either 1) a single-use, unopened, CO2/N2 incubator, 2) a multi-user, CO2/N2 incubator, 3) a CO2/N2 workstation, 4) a multi-user CO2/N2 incubator with media changes in a CO2/N2 workstation, 5) a pre-determined CO2/N2 gas concentration flushbox system [15], and 6) a multiuser CO2 incubator (Figure 2A). A single donor was selected at this point due to the statistical strength associated with the use of GHSLO2% (Figure 1B, C, and D). The frequency and nature of ambient oxygen exposure events are detailed in Table 1. Statistical evaluation was performed with a Paired Students T-Test vs. 20% O2 in all instances. All media changes were performed in a standard Class II Biological Safety Cabinet unless otherwise stated. Surprisingly, the multi-user, CO2/N2 incubator (125.3 CFU-F/T75 cm2) and the multi-user CO2/N2 incubator with media changes in a CO2/N2 workstation (126 CFU-F/T75 cm2) were comparable to the multiuser CO2 incubator (133 CFU-F/T75 cm2) in terms of BMhMSC CFU-F yield (p=0.53 and p=0.47, respectively, vs. 20% O2). As indicated in Table 1 this suggests that frequent ambient oxygen exposure events caused by incubator door opening during the recovery period can result in reductions in CFU-F yield. The optimal environmental control apparatus when used in combination with GHSL was either the single-user, unopened, CO2/N2 incubator (178.3 CFU-F/T75 cm2, p= 0.001 vs. 20% O2) or the CO2/N2 workstation (172.6 CFU-F/T75 cm2, p=0.01 vs. 20% O2). The flushbox system yield was comparable to the above (149 CFU-F/T75 cm2, p=0.063) but due to the inherent space constraints on the system and the susceptibility to mold contamination the system was not included in further analysis. The yields of BMhMSC CFU-F were comparable between the two optimal systems tested. The CO2/N2 workstation (2% O2WS) yielded a substantially greater number of BMhMSC per 106 MNC than the single-user, unopened, CO2/N2 incubator (2% O2) (9 X 104 vs. 5.83 X 104, respectively) (p=0.0001 and p=0.01, respectively, vs. 20% O2) (Figure 2B). This translates to a cell yield in a CO2/N2 workstation of 6.8 X 105 per T75 flask (Figure 2C). In all subsequent experiments, BMhMSC isolated in single-user, unopened, CO2/N2 incubator (2% O2) are referred to as GHSLO2% whereas BMhMSC isolated in the CO2/N2 workstation (2% O2WS) are referred to as GHSLO2%WS. In real terms the primary difference between the two optimal systems (GHSLO2% and GHSLO2%WS) was approximately 10 minutes of air exposure during media changes, which were performed in a biological safety cabinet, to GHSLO2% emphasizing the importance of continuous oxygen control during the recovery of BMhMSC.

Functional characterization of hMSC requires evidence of immunophenotype and differentiation capacity [2]. As anticipated adipogenic, osteogenic and chondrogenic differentiation capacity were evident in BMhMSC irrespective of isolation environment (Figure 3A). The efficiency of differentiation appeared altered but was not quantified; adipogenesis and osteogenesis levels were reduced whereas chondrogenesis was enhanced in GHSLO2% vs. GHSHO20%. Adipogenic and osteogenic differentiation levels of GHSLO2% recovered BMhMSC were restored by switching into 20% O2 for the duration of the differentiation time course. Immunophenotypic characterization demonstrated that, irrespective of the isolation environment, BMhMSC displayed strong expression of STRO-1, CD44, CD90, and CD146 and absent or limited expression of CD14 and CD19 (Figure 3B). STRO-1 expression was significantly higher in GHSLO2% than in GHSHO20% at P0 (95% GHSLO2% vs 79% GHSHO20%, p<0.001) but expression levels rapidly dropped in all conditions with subsequent passage and culture (P1) (Figure 3C, 3D). These characterizations confirm that cells isolated under GHSLO2% are BMhMSC in both 2% O2 and 2% O2WS.

Global transcriptome analysis provides a powerful interrogational tool for the rapid identification of transcript alterations and representative pathway bias in biological samples [7,18,51-53]. The frequencies of BMhMSC CFU-F isolation were similar in 2% O2 and 2% O2WS which led us to hypothesize that a core set of transcripts would be differentially expressed in comparison to GHSHO20%. To test this hypothesis we isolated BMhMSC from a single bone marrow donor in either GHSLO2%WS, GHSLO2%, or GHSHO20% conditions, in quadruplicate flasks. A single donor was selected for candidate gene identification with additional donors included for the later candidate verification (qRT-PCR) and mechanistic determination. RNA was isolated from each independent replicate flask and maintained as a unique experimental replicate throughout processing steps and hybridized to individual Exon 1.0ST array chips. We identified 71 and 68 downregulated probe sets in GHSLO2% and GHSLO2%WS, respectively vs. GHSHO20% which correlated to 61 unique genes in each while 16 were held in common (Figure 4A, Supplementary Tables 1 and 2, Supplementary Dataset 1). We next identified 226 and 232 upregulated probesets in GHSLO2% and GHSLO2%WS , respectively vs. GHSHO20% which correlated to 145 (GHSLO2%) and 156 (GHSLO2%WS) unique genes in each where 67 were held in common (Figure 4A, Supplementary Tables 3 and 4, Supplementary Dataset 1). This identified a core set of 16 downregulated and 67 upregulated transcripts in GHSLO2% vs. GHSHO20% hMSCs (Figure 4A). Subsequent analysis identified 63 and 37 probe sets differentially overexpressed between GHSLO2% and GHSLO2%WS, respectively which correlated to 57 (GHSLO2%) and 27 (GHSLO2%WS) unique genes with no observed overlap (Figure 4A). qRT-PCR provided confirmation of transcriptional changes for a subset of differentially expressed genes from the core set (CXCL1, PTGIS and ACAN) (Figure 4B). qRTPCR was performed using triplicate independent RNA isolates from BMhMSC isolated from three independent donors.






Several often contradictory reports describe the isolation and /or subsequent culture and characterization of hMSC in reduced oxygen tensions. Quantification of CFU-F suggests that in reduced oxygen tensions colony numbers and colony size can be either reduced, increased, or stay the same when compared to ambient air recovered hMSC [21,22,25,29,32,33]. Less contradictory, though still not consistent, are the descriptions of increased cell numbers and decreased expansion times in reduced oxygen vs. ambient air recovered cells [5,10,23,26-28,34-37]. Through a combination process of optimized culture conditions coupled to examination of oxygen control equipment, we have determined that much of the previous variation in hMSC CFU-F frequency can be attributed to the equipped level of oxygen control: tighter control via removal of multiple door openings during the recovery period appeared to associate with a significantly increased frequency of CFU-F isolation and absolute BMhMSC numbers.

There is a major interpretative difficulty which emerges as the broad range of isolation parameters which are described for hMSC becomes apparent. For instance, oxygen tensions and serum concentrations ranging from 1% O2 to 5% O2 and 5% to 20% serum, respectively, have all been applied to previous descriptions of reduced oxygen hMSC isolation [5,10,21-23,25-29,34-37]. In this study mean colony yield was not significantly different between isolation conditions which incorporated either GH or GL (mean CFU-F’s of 34 and 40, respectively), SH or SL (mean CFU-F’s of 33 and 41, respectively), or either of O20%, O2%, orO0.2% (mean CFU-F’s of 34, 41, and 36, respectively) (Figure 1A). Differences were apparent but a combination of factors (GHSLO2%) was required to optimize CFU-F isolation to significant levels above other conditions (Figure 1B-D). The optimization step allowed the impact of engineered oxygen control measures to be explored with confidence. The subsequent incorporation of tighter oxygen control measures resulted in significant improvements in CFU-F isolation above those seen for medium/environment optimization alone (Figure 2). It is important to note that a strong correlation emerged between a multi-user incubation environment and reduced BMhMSC yield. This was hypothesized to be in some part due to a cumulative effect of a repeated cycle of chamber reoxygenation, media reoxygenation, chamber deoxygenation, and media deoxygenation and not due to air exposure during media changes (Figure 2 and Table 1).

Our experiments have adopted the D’Ippolito et al (2004) method, with minor modifications in a slight reduction of maintenance O2 used, and the adoption of a hermetically tight workstation for impact evaluation [10]. However, switching BMhMSC into a 2% FBS supplemented media for expansion did not yield immortal hMSC as previously reported [10]. As a direct consequence of multiparametric analysis, we concluded that GHSLO2% is the optimum condition for BMhMSC recovery where serum and oxygen levels are the critical components.

Consensus immunophenotypic profiles of hMSC in reduced oxygen versus ambient air oxygen levels suggest a largely unchanged profile (CD13, CD29, CD73, CD90, CD105, CD166, CD271, and HLA-1) with some accompanying increases (CD106 and STRO-1) in surface antigen expression levels [22,34,54]. Non-quantitative (CD44, CD90, CD146) and quantitative (STRO-1) analysis of immunofluorescence images in our study is in broad agreement with these previous reports. A defining characteristic of hMSCs is their multipotent differentiation potential [2]. The effect of reduced oxygen culture on differentiation is described across multiple reports where general differentiation potential is retained but capacity frequently altered. Similarly, the above reports do not allow a reliable consensus on the effects of oxygen tension on differentiation potential. Most describe osteogenic potential of hMSC as reduced [5,23,26-28,30,32], while in others this osteogenic capacity is enhanced [25,31] or unchanged [53;55]. Adipogenic differentiation is similarly described as being enhanced [5,24,25,32] or reduced [23,26,27], while chondrogenic potential is generally referred to as enhanced [5,54,56,57]. We observed retention of osteogenic, adipogenic, and chondrogenic differentiation potential in all conditions but some evidence of reduced osteogenic and adipogenic potential in hypoxic conditions. Further studies will be required to elaborate the role of oxygen and optimized culture conditions during differentiation.

Transcriptome determination provides an invaluable tool in developing mechanistic understanding in cell behavior and response to environment alteration. We identified a consensus optimized BMhMSC fingerprint of 80 differentially expressed (16 downregulated and 64 upregulated) genes. These transcripts were modulated in both 2% O2 and 2% O2WS, and over-represented in identical ontology groups. A surprising paucity of data exists with which we can compare, contrast and evaluate our findings. Downregulation of transcripts associated with DNA metabolism, cell cycle progression, and chromosome adhesion (RRM2, XRCC2, KIF24, POLQ, E2F8, FANCD2, ESCO2, AVRKB, CENP2, MKI67) and upregulation of transcripts associated with adhesion and metabolism pathways (CD93, ESAM, VWF, PLVAP, ANGPT2, LEP, and TCF1, ZP1, GIMAP4, PCDH17) was reported in P0 hMSC [22]. No conservation with consensus fingerprint was immediately apparent although 2% O2 (GHSLO2%) BMhMSC display differential upregulation of LEP, albeit outside of the consensus fingerprint, whereas LEPR is within the consensus fingerprint. LEPR is homologous to members of the gp130 receptor superfamily and acts as a receptor for the pleiotropic signaling molecule, leptin, which has roles in metabolism, reproduction, pregnancy, angiogenesis, growth, and immunomodulation [58]. Previous reports describe hMSC LEP expression modulation in hypoxic conditions with alternate outcomes [22;24]. To our knowledge, we are the first to report BMhMSC LEPR upregulation in a reduced oxygen environment. The precise mechanistic consequence of LEPR upregulation in GHSLO2% BMhMSC remains to be determined and it cannot be excluded at this point that the upregulation of LEPR may be as a consequence of the reduced serum (SL) utilized in the optimized culture milieu.

Ontological examination of the 80 transcript BMhMSC fingerprint revealed a strong over-representation in specific areas complemented by significant CCRI KEGG pathway association (Supplementary Tables 5, 6, 7, and 8). These findings highlighted downregulation of both BMP2 and IL8 receptor (CXCR2) signaling pathways as relevant to optimized BMhMSC recovery and mechanistic understanding. The importance of oxygen control was readily apparent by the increased associations with CCRI and significant association with TGFβ signaling for O2%WS above that noted for O2% only (Figure 6). The base media, GHSL, was consistent in this instance allowing clear dislocation and emphasis to be placed on the importance of controlled oxygen measures on BMhMSC biology. CXCL1 (GROα) and CXCL6 (GCP-2), both agonists for CXCR2, are pro-inflammatory cytokines with apparent roles in neutrophil attraction, angiogenic induction, stem cell self-renewal (GROα), and the transition of cells from suspension to substrate adherence through integrin activation [59-62]. The mechanistic role of CXCL1 and CXCL6 repression is unclear at this time and it cannot be excluded that this is a consequence of SL vs. SH as opposed to the use of a reduced oxygen environment. Hypoxic repression of BMP2 has been reported previously but is predominantly associated with repression of osteogenic differentiation of hMSC [55,63]. A single report details an association of reduced BMP2 expression with enhanced hMSC isolation from the placental decidua basalis [64]. Here, we have demonstrated that BMP2 protein inhibits BMhMSC recovery in GHSLO2% and provide clear lines of evidence supportive of a role for oxygen signaling in its repression. 












	Bone marrow-derived mesenchymal stem cell isolation is enhanced under controlled physiological oxygen and reduced serum conditions.
	Routine conditions for bone marrow-derived mesenchymal stem cell isolation incorporating ambient air and 10% serum result in reduced cell yields.
	Repeated opening of multi-user trigas incubator can result in reduced bone marrow-derived mesenchymal stem cell yields in comparison to workstation or single-use trigas incubators.
	Minimal and transient exposure to ambient air during isolation can significantly reduce cell numbers and impact on transcriptional profiles.
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Figure 1. Physiological normoxia and serum synergistically promote BMhMSC isolation. A) Bone marrow aspirate was seeded across a matrix of conditions including high (4.5 g/L) and low (1.0 g/L) glucose media (GH and GL), high (10%) and low (5%) serum (SH and SL), and physiological hyperoxia (20% O2), normoxia (2% O2), and hypoxic (0.2% O2) culture atmosphere oxygen concentrations (O20%, O2%, O0.2%). Optimal BMhMSC recovery was associated with GLSL and SLO2% combinations where GHSLO2%.and GLSLO2% supported maximum BMhMSC CFU-F yields (n=3 independent donors in triplicate). GLSL did not promote subsequent BMhMSC expansion. B), C), and D) describes increased CFU-F per T75 flask, BMhMSC per T75 flask, and BMhMSC (104) per MNC (106) seeded, respectively, for GHSLO2% vs. GHSLO21% and GHSHO21% (n=6 independent donors in triplicate). Error bars indicate standard error. * indicates p<0.05 vs. GHSLO2%, ** indicates p=0.001 vs. GHSLO2%.


Figure 2. Repeated air oxygen exposure is refractory to hMSC recovery. Bone marrow aspirate was seeded into flasks containing GHSLO2% across a number of systems in common use for control of cell culture O2 levels. A) BMhMSC were recovered in either standard incubator (20% O2) (black bar), flushbox (2% O2) (horizontal striped bar), single user tri-gas incubator (2% O2) (open bar), multi-user tri-gas incubator (2% O2) (grey bar), workstation (2% O2) (vertical striped bar), and multi-user tri-gas incubator with workstation for handling (2% O2) (vertical striped grey bar). CO2 was maintained at 7% in all instances with N2 to balance and temperature constant at 37oC. Unless otherwise stated all culture handling was performed rapidly in a standard biological safety cabinet. B) and C) describe BMhMSC recovered per MNC seeded and BMhMSC recovered per T75 flask where enhanced isolation was observed in 2% O2 workstation vs. 2% O2 single user tri-gas incubator vs. 20% O2 standard incubator (n=3). *p=0.01, **p=0.001, ***p=0.0001.


Figure 3. Multipotentiality and immunophenotypic retention of hMSC isolated in optimized conditions. A) Osteogenic (Osteo), chondrogenic (Chondro), and adipogenic (Adipo) differentiation in GHSHO21% isolated hMSC vs. GHSLO2% and GHSLO2%WS isolated BMhMSC display broad multipotential differentiation retention with anticipated inhibition and enhancement as reported previously. Reductions in adipogenic and osteogenic differentiation are recovered by switching BMhMSC back into 20% for differentiation (GHSLO2%→20% and GHSLO2%WS→20%). B) Immunophenotypes of BMhMSC isolated in either GHSHO20%, GHSLO2%, or GHSLO2%WS are broadly similar. Individual CD markers tested are indicated on the left-hand side of panels. C, D) Sub-population of STRO-1 expressing BMhMSCs in passage 0 and passage 1 cells detected by fluorescent immunocytochemistry (C) and quantified (D) (n=3). Nuclei are counterstained with DAPI. Scale bar indicates 100µm throughout. * indicates p<0.05 vs. GHSHO20%, ** indicates p<0.01 vs. GHSHO20% (Passage 0 or Passage 1).


Figure 4. Transcriptome analysis identifies differentially expressed genes in GHSHO20% vs. GHSLO2% isolated BMhMSC. BMhMSC were lysed after three weeks recovery, RNA extracted, and analysed using Exon1.0ST arrays before being exported as U133 Plus2.0 data. A) GHSLO2% isolated BMhMSC displayed downregulation of 61 genes in comparison to GHSHO21% where 16 were held in common between 2% O2 workstation and single-use 2% O2 incubator. Upregulation of 145 and 156 genes were noted in GHSLO2% and GHSLO2%WS isolated BMhMSC vs. GHSHO20% isolates where 67 were held in common. GHSLO2% and GHSLO2%WS isolated hMSC isolated BMhMSC displayed distinct differential gene expression when directly compared with no apparent overlap. B) QRT-PCR provided confirmation of differential expression of CXCL1, PTGIS, and ACAN. Error bars indicate Standard Error. * indicates p≤0.005 vs. GHSHO21%. See also Supplementary Tables 1-4 and Supplementary Dataset 1.

Figure 5. Gene ontology analysis identifies specific terms associated with differentially expressed genes in GHSHO20% vs. GHSLO2% and GHSLO2%WS. A) GO terms significantly under-represented in GHSLO2% and GHSLO2%WS vs. GHSHO20%.are identified in CC, BP, and MP hierarchies. Common under-representation includes cytokine activity (MF), regulation of proliferation (BP), external stimuli response (BP), and shape development (BP) terms. B) Over-representation vs. GHSHO20% was also noted across the three main hierarchies. Common terms included small GTPase regulation (MF), adhesion and development (both BP), plasma membrane and extracellular region (CC). C) No common GO terms were noted for GHSLO2% vs. GHSLO2%WS. Values indicate number of GO terms associated per hierarchy per grouping. See also Supplementary Tables 5-8 for listings of all GO terms identified and Affymetrix probes and associated genes of all common identified GO terms.

Figure 6. Differentially expressed genes associate with specific KEGG pathways. A) DAVID-based evaluation of differentially expressed genes revealed significant association of GHSLO2% (p=0.0067) and GHSLO2%WS (p=0.04) downregulated genes with the Cytokine-Cytokine Receptor Interaction Pathway (CCRI). This was highlighted by downregulation of both BMP2 and CXCR2. Similarly DAVID-based evaluation of the core differential expression transcripts revealed a significant association with CCRI (p=0.035) again through down-regulation of BMP2 and CXCR2. B) DAVID analysis identified a significant association (p=0.01) of GHSLO2%WS vs. GHSHO20%.differential expression with TGFβ through BMP downregulation and Noggin upregulation. Red boxed genes indicate downregulation in GHSLO2% and/or GHSLO2%WS as specified, blue boxes indicate up regulation.







This table provides a listing of all differentially overexpressed genes in GHSHO20%. vs. GHSHO2%. Figure 4A lists only the GHSHO20% genes also overexpressed in GHSHO2%WS.

Supplementary Table 2.
This table provides a listing of all differentially overexpressed genes in GHSHO20%. vs. GHSHO2%WS. Figure 4A lists only the GHSHO20% genes also overexpressed in GHSHO2%.

Supplementary Table 3.
This table provides a listing of all differentially overexpressed genes in GHSHO2%. vs. GHSHO20%. Figure 4A lists only the GHSHO2% genes also overexpressed in GHSHO2%WS.

Supplementary Table 4.
This table provides a listing of all differentially overexpressed genes in GHSHO2%WS. vs. GHSHO20%. Figure 4A lists only the GHSHO2%WS genes also overexpressed in GHSHO2%.

Supplementary Table 5.
This table provides a listing of all GO terms associated with differential overexpression in GHSHO20%. vs. GHSHO2% and GHSLO2%WS. Figure 5A lists only those GO terms which are commonly identified between conditions tested.

Supplementary Table 6.
This table lists the genes which are associated with the over-represented and commonly associated GO terms listed in Figure 5A and Table S5B.

Supplementary Table 7.
This table provides a listing of all GO terms associated with differential overexpression in GHSHO2% and GHSLO2%WS vs. GHSHO20%. Figure 5B lists only those GO terms which are commonly identified between conditions tested.

Supplementary Table 8.
This table lists the genes which are associated with the over-represented and commonly associated GO terms listed in Figure 5B and Table S5C.

Supplementary Dataset 1.
This worksheet provides a comprehensive breakdown of all primary expression values as exported from DChip and their subsequent manipulations during data analysis.
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